demonstrated in an Apo E−/− murine atherosclerosis model that hematopoietic stem cell-specific Glut1 deletion significantly suppressed glycolytic activity, identifying Glut1-mediated glycolysis as a pivotal metabolic driver of atherosclerosis (39). The gene discussed is SLC2A1; the disease is atherosclerosis.